Aktiesnakken — November 2009
-
ja det er hårdt at være chef....men 28 mill er i orden
-
tak porter....og ndrs, ja genmab er lige spændende nok
-
ja nrds
-
ved godt at nogen selv kan have brug for det ovenpå GEN. Her er lidt af det jeg leder efter: http://www.binvest.dk/beskraeg.htm
-
i refrac....
-
i de andre indikationer ligger det omkring 33K dollar for en behandling, på grund af
-
just precis....du har slet ikke behov for mig
-
der er ret meget tvivl om sammenskrueningenen af den aftale. men royalties ligger nok mellem 20-35%, men muligvis en del i begyndelsen
-
ja vi tror på at de ikke skal hente flere penge
-
nej det kan man ikke just mene, men kursen kære ndrs....
-
god weekend ndrs
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind